Neogenomics (NEO) Inventory Average (2011 - 2026)

Neogenomics has reported Inventory Average for 16 years, with the latest figure at $29.2 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory Average rose 3.33% year-over-year to $29.2 million; the trailing twelve-month figure through Mar 2026 stood at $29.2 million (up 3.33% YoY), and the FY2025 full-year result was $27.7 million, up 8.66% from the prior year.
• Inventory Average for Q1 2026 stood at $29.2 million, up from $28.5 million in the prior quarter.
• The five-year high for Inventory Average was $32.0 million in Q2 2025, with the low at $21.8 million in Q2 2024.
• Historically, Inventory Average has averaged $25.5 million across 5 years, with a median of $24.4 million in 2023.
• Annual changes were most pronounced in 2024 — Inventory Average retreated 11.83% — and 2025, when it surged 46.88%.
• Neogenomics' Inventory Average stood at $24.0 million in 2022, then gained by 0.28% to $24.1 million in 2023, then increased by 6.21% to $25.6 million in 2024, then increased by 11.37% to $28.5 million in 2025, then grew by 2.41% to $29.2 million in 2026.
• The last three Inventory Average figures came in at $29.2 million (Q1 2026), $28.5 million (Q4 2025), and $31.3 million (Q3 2025), per Business Quant data.